@gltrax1: The FDA just added a warning to 12 GLP-1 drugs — Ozempic, Wegovy, Mounjaro, Zepbound, Foundayo and more — about a rare eye condition called NAION. The headlines are scary. Here's what it actually says. 🦎 NAION is sudden, painless vision loss in one eye. It can be permanent. The FDA looked at 126 trials — 134,000+ people — and found 15 probable cases: 10 on a GLP-1, 5 on placebo. That's 6.4 cases per 100,000 people per year. Rare. But real enough that the FDA wants it on every label. What the FDA did NOT say: that the drugs cause it. The risk is described as "potential" — and nothing was recalled or withdrawn. What the FDA DOES say: if you notice sudden vision loss or a blind spot in one eye, tell your doctor right away. And don't stop your meds on your own — talk to your doctor first. Share this with someone on a GLP-1 — they'd want to know. Did your doctor ever mention eye symptoms to watch for? Tell me below. 👇 Source: FDA Drug Safety Communication, Nov 9, 2026. Educational only — not medical advice. Talk to your doctor. #GLP1 #GLP1Journey #Mounjaro #Zepbound #Wegovy #Ozempic #WeightLossJourney #GLTrax

GLTrax

Open In TikTok:

Region: US

Tuesday 10 November 2026 03:41:07 GMT